scholarly journals Nondepolarizing muscle relaxant improves direct laryngoscopy view with no effect on face mask ventilation

2017 ◽  
Vol 67 (4) ◽  
pp. 383-387 ◽  
Author(s):  
Marwan S. Rizk ◽  
Salah M. Zeineldine ◽  
Mohamad F. El-Khatib ◽  
Vanda G. Yazbeck-Karam ◽  
Sophie D. Ayoub ◽  
...  
2013 ◽  
Vol 119 (6) ◽  
pp. 1360-1369 ◽  
Author(s):  
Sachin Kheterpal ◽  
David Healy ◽  
Michael F. Aziz ◽  
Amy M. Shanks ◽  
Robert E. Freundlich ◽  
...  

Abstract Background: Research regarding difficult mask ventilation (DMV) combined with difficult laryngoscopy (DL) is extremely limited even though each technique serves as a rescue for one another. Methods: Four tertiary care centers participating in the Multicenter Perioperative Outcomes Group used a consistent structured patient history and airway examination and airway outcome definition. DMV was defined as grade 3 or 4 mask ventilation, and DL was defined as grade 3 or 4 laryngoscopic view or four or more intubation attempts. The primary outcome was DMV combined with DL. Patients with the primary outcome were compared to those without the primary outcome to identify predictors of DMV combined with DL using a non-parsimonious logistic regression. Results: Of 492,239 cases performed at four institutions among adult patients, 176,679 included a documented face mask ventilation and laryngoscopy attempt. Six hundred ninety-eight patients experienced the primary outcome, an overall incidence of 0.40%. One patient required an emergent cricothyrotomy, 177 were intubated using direct laryngoscopy, 284 using direct laryngoscopy with bougie introducer, 163 using videolaryngoscopy, and 73 using other techniques. Independent predictors of the primary outcome included age 46 yr or more, body mass index 30 or more, male sex, Mallampati III or IV, neck mass or radiation, limited thyromental distance, sleep apnea, presence of teeth, beard, thick neck, limited cervical spine mobility, and limited jaw protrusion (c-statistic 0.84 [95% CI, 0.82–0.87]). Conclusion: DMV combined with DL is an infrequent but not rare phenomenon. Most patients can be managed with the use of direct or videolaryngoscopy. An easy to use unweighted risk scale has robust discriminating capacity.


2021 ◽  
Vol 87 (1) ◽  
Author(s):  
Amedeo BIANCHINI ◽  
Ludovica NARDOZI ◽  
Elena NARDI ◽  
Maria F. SCUPPA
Keyword(s):  

2013 ◽  
Vol 44 (5) ◽  
pp. 1028-1033 ◽  
Author(s):  
Danielle Hart ◽  
Robert Reardon ◽  
Christopher Ward ◽  
James Miner
Keyword(s):  

1993 ◽  
Vol 26 (1) ◽  
pp. 50
Author(s):  
Jin Seung Lee ◽  
Jang Weon Lee ◽  
Si Young Ok ◽  
Yoo Jae Kim ◽  
Wook Park ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e025909 ◽  
Author(s):  
Mickael Vourc’h ◽  
Donatien Huard ◽  
Fanny Feuillet ◽  
Gabrielle Baud ◽  
Arthur Guichoux ◽  
...  

IntroductionAlthough preoxygenation and airway management respond to precise algorithms, difficult intubation (DI) remains a daily challenge in intensive care units and in the operating rooms because of its frequent complications, including hypoxaemia. To prevent desaturation during DI, high-flow oxygenation by nasal cannula (HFNC) could prove beneficial. Indeed, contrary to standard preoxygenation device, it can be held in place throughout the intubation trying to perform apnoeic oxygenation during DI. Hence, recent guidelines recommend HFNC during DI, but its relevance has never been evaluated in this setting in a large randomised study until now.Methods and analysisThe PREOPTIDAM trial is a prospective, single-centre, randomised, controlled study in Nantes University Hospital. In anticipated DI, we hypothesised that HFNC can decrease the incidence of desaturation ≤94% or face mask ventilation from 16% to 4% compared with standard device. Using a two-sided t-test with a first species risk of 5% and 80% power, a total of 186 patients will be included. Using a computer-generated randomisation, with a 1:1 allocation ratio, patients will be randomised to HFNC or face mask preoxygenation. Randomisation will be stratified on intubation sequence: Rapid sequence intubation or awake fibreoptic intubation. The primary objective is to determine whether HFNC is more efficient than standard oxygenation techniques to prevent desaturation ≤94% or face mask ventilation during DI. Intent-to-treat and per-protocol analysis are planned for the primary outcome.Ethics and disseminationThe study project has been approved by an independent ethics committee. Written informed consent will be obtained before study inclusion. Participant recruitment begins in September 2018. Results will be submitted to international peer-reviewed medical journals.Trial registration numberNCT03604120.


Sign in / Sign up

Export Citation Format

Share Document